It also examines the relationship between the concentrations of CXCL1, CXCR1, and C-reactive protein (CRP), a marker of inflammation in CRC patients, which allows us to better understand the link between inflammation and tumor development. This evidence concerns the gene CRP and colorectal carcinoma.